Top ASX stocks to buy right now with $7,000

Analysts think these shares would be top picks for your money.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you've got $7,000 ready to invest, now might be a great time to snap up some high-quality ASX stocks at discounted prices.

The Australian market has seen some volatility recently, and several top-tier companies have pulled back from their highs, presenting attractive buying opportunities for long-term investors.

Let's take a look at three shares that analysts are tipping as top ASX stocks to buy now:

Man holding Australian dollar notes, symbolising dividends.

Image source: Getty Images

WiseTech Global Ltd (ASX: WTC)

The first ASX stock to look at is WiseTech Global. It is a world leader in logistics software, with its flagship CargoWise One platform used by some of the biggest freight and logistics companies globally. The company has built an incredibly strong competitive position, helping businesses streamline their supply chain operations with cutting-edge technology.

Despite this strength, its share price has fallen materially from recent highs, creating a potential buying opportunity for investors. Goldman Sachs remains bullish on WiseTech. It said:

We are positive on WiseTech's strong competitive position which contributes to efficiency gains for LGFF's. Over the short-to-medium term we expect WiseTech's earnings profile to benefit from new product releases such as Container Transport Optimizer, as well as the company continuing to grow penetration of their core business.

Goldman has a buy rating and $128.00 price target on its shares.

Light & Wonder Inc (ASX: LNW)

Light & Wonder is a global gaming company that has been delivering impressive results despite some legal headwinds. The company operates in land-based and digital gaming, with its slot machines and casino technology seeing strong demand worldwide.

Morgans is particularly positive about the company's outlook, stating:

Looking ahead, the company has guided to low double-digit Adj-EBITDA growth in 1Q25, which we expect to accelerate through the year. With resilient US slot demand, strong gaming ops expansion and disciplined cost management, we believe LNW remains well-positioned for continued outperformance.

The broker has put an add rating and $220.00 price target on this top ASX stock.

Pro Medicus Limited (ASX: PME)

A final top ASX stock to buy this month with $7,000 is Pro Medicus. It is a top-tier ASX medical technology stock that has built an enviable position in the medical imaging industry with its Visage solution. The company's high-margin software is used by hospitals and radiology providers to improve efficiency and reduce costs—an offering that has seen strong demand despite its premium price tag.

With its shares down heavily from their 52-week high, analysts believe a compelling buying opportunity has been created. Commenting on the company, Bell Potter recently said:

The PME full stack solution continues to wipe the floor with competitors – 10 contract announcements in the LTM including two new academic medical centres clients. […] We see no stopping the current momentum in new contract wins with margins more likely to grow as hospitals begrudgingly adopt the Visage despite its premium price, due to the absence of any viable alternative to meet productivity requirements.

Bell Potter has a buy rating and $330.00 price target on the stock.

Motley Fool contributor James Mickleboro has positions in Pro Medicus and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Light & Wonder, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Light & Wonder and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Growth Shares

10 excellent ASX shares to buy in May

Here is a selection of high-quality shares that could be in the buy zone this month.

Read more »

Man with a rocket strapped to his back on a tiny bicycle ready to take off.
Growth Shares

2 ASX shares tipped to grow 90% or more in the next 12 months!

These stocks have the potential to deliver major returns!

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Growth Shares

Down 67%, is this ASX 300 share a bargain buy?

A sharp share price decline has reset expectations, but the underlying growth story and market opportunity have not changed.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Growth Shares

2 high-quality ASX 200 shares experts rate as buys

These stocks are top-rated by some of Australia’s top brokers.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Growth Shares

3 amazing ASX 200 shares to buy with $5,000 in May

Analysts are recommending these ASX 200 shares as buys.

Read more »

woman accessing her smart home from her phone
Growth Shares

This beaten-down ASX 200 growth stock could be one to watch

Demand for data centres is accelerating, but earnings are yet to catch up. That gap could define the opportunity from…

Read more »

A kid stretches up to reach the top of the ruler drawn on the wall behind.
Growth Shares

2 top ASX shares to buy and hold for the next decade

I really like these investments for the long term.

Read more »

A woman hangs from a cliff with raging waters below.
Growth Shares

The ASX's hottest shares just stumbled — warning sign?

Are expectations starting to outpace fundamentals?

Read more »